Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:fluvoxamine
|
| gptkbp:approvedBy |
gptkb:France
gptkb:Germany gptkb:Italy gptkb:Switzerland |
| gptkbp:ATCCode |
gptkb:N06AB08
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:contraindication |
concomitant use with MAO inhibitors
|
| gptkbp:discoveredIn |
1970s
|
| gptkbp:drugClass |
selective serotonin reuptake inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
Floxyfral
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Abbott_Laboratories
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache insomnia dry mouth |
| gptkbp:usedFor |
gptkb:depression
gptkb:obsessive-compulsive_disorder |
| gptkbp:bfsParent |
gptkb:fluvoxamine
|
| gptkbp:bfsLayer |
6
|